LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

<<<<

Select the entities to show:

Small molecules	Cells

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
MDA-MB-231	QL-X-138	10.0	uM	LJP6	3	F19	72	hr	868	865	3486	0.2481	-0.0012
MCF7	Celastrol	0.37	uM	LJP6	3	G10	72	hr	1235	2217	4156	0.5334	0.3361
Hs 578T	Ruxolitinib	10.0	uM	LJP5	3	O13	72	hr	929	2354	3228	0.7292	0.6198
MDA-MB-231	Seliciclib	10.0	uM	LJP5	3	J01	72	hr	868	1461	3486	0.4191	0.2264
MDA-MB-231	Radicicol	10.0	uM	LJP5	3	K07	72	hr	868	1076	3486	0.3086	0.0794
MDA-MB-231	Radicicol	10.0	uM	LJP6	3	K07	72	hr	868	1069	3486	0.3066	0.0767
MCF7	CGP60474	0.37	uM	LJP6	3	G04	72	hr	1235	564	4156	0.1357	-0.2299
Hs 578T	Saracatinib	10.0	uM	LJP6	3	D07	72	hr	929	1648	3228	0.5105	0.3127
BT-20	Trametinib	10.0	uM	LJP5	3	P19	72	hr	1657	4384	5505	0.7963	0.7085
MCF7	CP724714	0.37	uM	LJP5	3	A10	72	hr	1235	3494	4156	0.8407	0.7733
MDA-MB-231	Saracatinib	10.0	uM	LJP6	3	D07	72	hr	868	1818	3486	0.5215	0.3628
BT-20	GSK 690693	0.12	uM	LJP5	3	F23	72	hr	1657	4807	5505	0.8731	0.8184
MCF7	CHIR-99021	0.37	uM	LJP6	3	P16	72	hr	1235	3301	4156	0.7942	0.7072
MDA-MB-231	SU11274	10.0	uM	LJP5	3	J07	72	hr	868	1269	3486	0.3640	0.1531
MCF7	Crizotinib	0.37	uM	LJP5	3	A22	72	hr	1235	2453	4156	0.5902	0.4169
BT-20	PHA-793887	0.04	uM	LJP6	3	E24	72	hr	1657	3106	5505	0.5642	0.3764
MDA-MB-231	Sirolimus	10.0	uM	LJP6	3	L13	72	hr	868	3144	3486	0.9018	0.8692
MCF7	CP466722	0.37	uM	LJP5	3	I10	72	hr	1235	4833	4156	1.1629	1.2317
Hs 578T	SU11274	10.0	uM	LJP5	3	J07	72	hr	929	1385	3228	0.4291	0.1983
MDA-MB-231	Sorafenib	10.0	uM	LJP6	3	B07	72	hr	868	2414	3486	0.6924	0.5904